Body Mass Index and Mortality in CKD

American Journal of Kidney Diseases

Volumn 50, Issue 3, 2007, Pages 404-411

  Madero, Magdalena ^a   Sarnak, Mark J ^a   Wang, Xuelei ^b   Sceppa, Carmen Castaneda ^c   Greene, Tom ^d   Beck, Gerald J ^b   Kusek, John W ^e   Collins, Allan J ^f   Levey, Andrew S ^a   Menon, Vandana ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c TUFTS UNIVERSITY   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

cardiovascular mortality; Kidney disease; outcomes

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DIET; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODEL; PROTEIN RESTRICTION; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL RATE;

BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED;

EID: 34548007923     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.06.004     Document Type: Article

References (26)

1. Kuczmarski R.J., and Flegal K.M. Criteria for definition of overweight in transition: Background and recommendations for the United States. Am J Clin Nutr 72 (2000) 1074-1081
2. Flegal K.M., Carroll M.D., Ogden C.L., and Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
3. Byers T. Body-mass index and mortality. N Engl J Med 342 (2000) 286-287 author reply, 289
4. Manson J.E., Willett W.C., Stampfer M.J., et al. Body weight and mortality among women. N Engl J Med 333 (1995) 677-685
5. Calle E.E., Rodriguez C., Walker-Thurmond K., and Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348 (2003) 1625-1638
6. Kalantar-Zadeh K., Kopple J.D., Kilpatrick R.D., et al. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 46 (2005) 489-500
7. Kalantar-Zadeh K., Abbott K.C., Salahudeen A.K., Kilpatrick R.D., and Horwich T.B. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 81 (2005) 543-554
8. Kalantar-Zadeh K., Kuwae N., Wu D.Y., et al. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 83 (2006) 202-210
9. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
10. Hsu C.Y., McCulloch C.E., Iribarren C., Darbinian J., and Go A.S. Body mass index and risk for end-stage renal disease. Ann Intern Med 144 (2006) 21-28
11. Kramer H., Luke A., Bidani A., Cao G., Cooper R., and McGee D. Obesity and prevalent and incident CKD: The Hypertension Detection and Follow-Up Program. Am J Kidney Dis 46 (2005) 587-594
12. Gelber R.P., Kurth T., Kausz A.T., et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 46 (2005) 871-880
13. Muntner P., He J., Astor B.C., Folsom A.R., and Coresh J. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: Results from the Atherosclerosis Risk in Communities Study. J Am Soc Nephrol 16 (2005) 529-538
14. Evans M., Fryzek J.P., Elinder C.G., et al. The natural history of chronic renal failure: Results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis 46 (2005) 863-870
15. Buckalew Jr. V.M., Berg R.L., Wang S.R., Porush J.G., Rauch S., and Schulman G. Prevalence of hypertension in 1,795 subjects with chronic renal disease: The Modification of Diet in Renal Disease Study baseline cohort. Modification of Diet in Renal Disease Study Group. Am J Kidney Dis 28 (1996) 811-821
16. Klahr S., Levey A.S., Beck G.J., et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330 (1994) 877-884
17. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-The evidence report. Obes Res 6 suppl 2 (1998) S51-S209
18. Kuczmarski R.J., Flegal K.M., Campbell S.M., and Johnson C.L. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 272 (1994) 205-211
19. Iribarren C., Sharp D.S., Burchfiel C.M., and Petrovitch H. Association of weight loss and weight fluctuation with mortality among Japanese American men. N Engl J Med 333 (1995) 686-692
20. Shaper A.G., Wannamethee S.G., and Walker M. Body weight: Implications for the prevention of coronary heart disease, stroke, and diabetes mellitus in a cohort study of middle aged men. BMJ 314 (1997) 1311-1317
21. Johansen K.L., Young B., Kaysen G.A., and Chertow G.M. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 80 (2004) 324-332
22. Kalantar-Zadeh K., and Kopple J.D. Body mass index and risk for end-stage renal disease. Ann Intern Med 144 (2006) 701 author reply, 701-702
23. Kalantar-Zadeh K., Kilpatrick R.D., Kuwae N., and Wu D.Y. Reverse epidemiology: A spurious hypothesis or a hardcore reality?. Blood Purif 23 (2005) 57-63
24. Hsu C.Y. Body mass index and risk for end-stage renal disease. Ann Intern Med 144 (2006) 700-703
25. Kopple J.D., Levey A.S., Greene T., et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney Int 52 (1997) 778-791
26. Keith D.S., Nichols G.A., Gullion C.M., Brown J.B., and Smith D.H. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164 (2004) 659-663